CORRECTING and REPLACING BIOQUAL Presents Financial Results for Fiscal Year 2026
Business Wire•30/09/2026•12:16 ET
0
Key Highlights
- ➤Revenue $39,947,446 in fiscal 2026, down from $48,867,753
- ➤Net loss $4,168,571 in fiscal 2026, versus $1,048,154 loss
- ➤Basic EPS $(4.66), corrected from the prior release’s erroneous figure
- ➤Diluted EPS $(4.66), versus $(1.17) in fiscal 2025
Expert Statements
Hanne E. Andersen, President and CSO of BIOQUAL
“Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties.”
CORRECTING and REPLACING BIOQUAL Presents Financial Results for Fiscal Year 2026
Please replace the release dated September 22, 2026 with the following corrected version due to an error in the earnings per share price.
Get started
Create a free account to read the full story.